An inhibition enzyme immunoassay, using a human monoclonal antibody (K14) reactive with gp41 of HIV-1, for the serology of HIV-1 infections.
AIDS , Volume 5 - Issue 7 p. 893- 896
An inhibition enzyme immunoassay (IEIA), using a human monoclonal antibody (K14) reactive with gp41 of HIV-1, was evaluated for its applicability to the serology of HIV-1 infections. Using panels of serum samples from seronegative and confirmed HIV-1-seropositive individuals, it was shown that all the HIV-1-positive samples in a panel from The Netherlands and 97% of the HIV-1-positive samples from Tanzania were identified by this IEIA. Six per cent of the IEIA-positive samples from Tanzania could not be confirmed in other assays. Testing of serial dilutions of serum samples from African individuals with confirmed HIV-1, HIV-2 or HIV(ANI70) infections in the K14 IEIA, indicated that a HIV-1-specific assay based on this principle may be developed.
|, , , , , , , , ,|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
Teeuwsen, V.J.P, Schalken, J.J, van der Groen, G, van den Akker, R, Goudsmit, J, & Osterhaus, A.D.M.E. (1991). An inhibition enzyme immunoassay, using a human monoclonal antibody (K14) reactive with gp41 of HIV-1, for the serology of HIV-1 infections. AIDS, 5(7), 893–896. Retrieved from http://hdl.handle.net/1765/3425